Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

134 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Corrigendum to "Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance". [Rep. Pract. Oncol. Radiother. 20 (2015) 259-272].
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: macias v. Rep Pract Oncol Radiother. 2016 Jan-Feb;21(1):90-2. doi: 10.1016/j.rpor.2015.06.006. Epub 2015 Jul 20. Rep Pract Oncol Radiother. 2016. PMID: 26900365 Free PMC article.
Uroncor consensus statement: Management of biochemical recurrence after radical radiotherapy for prostate cancer: From biochemical failure to castration resistance.
López Torrecilla J, Hervás A, Zapatero A, Gómez Caamaño A, Macías V, Herruzo I, Maldonado X, Gómez Iturriaga A, Casas F, González San Segundo C. López Torrecilla J, et al. Among authors: macias v. Rep Pract Oncol Radiother. 2015 Jul-Aug;20(4):259-72. doi: 10.1016/j.rpor.2015.04.003. Epub 2015 May 30. Rep Pract Oncol Radiother. 2015. PMID: 26109913 Free PMC article. Review.
Late Radiation and Cardiovascular Adverse Effects After Androgen Deprivation and High-Dose Radiation Therapy in Prostate Cancer: Results From the DART 01/05 Randomized Phase 3 Trial.
Zapatero A, Guerrero A, Maldonado X, Álvarez A, González-San Segundo C, Cabeza Rodriguez MA, Macías V, Pedro Olive A, Casas F, Boladeras A, Martín de Vidales C, Vázquez de la Torre ML, Calvo FA. Zapatero A, et al. Among authors: macias v. Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):341-348. doi: 10.1016/j.ijrobp.2016.06.2445. Epub 2016 Jun 22. Int J Radiat Oncol Biol Phys. 2016. PMID: 27598804 Clinical Trial.
Estimating preferences for treatments in patients with localized prostate cancer.
Ávila M, Becerra V, Guedea F, Suárez JF, Fernandez P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Sancho G, Cunillera O, Pardo Y, Cots F, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Ávila M, et al. Among authors: macias v. Int J Radiat Oncol Biol Phys. 2015 Feb 1;91(2):277-87. doi: 10.1016/j.ijrobp.2014.09.044. Epub 2014 Dec 6. Int J Radiat Oncol Biol Phys. 2015. PMID: 25491504
High-dose radiotherapy with short-term or long-term androgen deprivation in localised prostate cancer (DART01/05 GICOR): a randomised, controlled, phase 3 trial.
Zapatero A, Guerrero A, Maldonado X, Alvarez A, Gonzalez San Segundo C, Cabeza Rodríguez MA, Macias V, Pedro Olive A, Casas F, Boladeras A, de Vidales CM, Vazquez de la Torre ML, Villà S, Perez de la Haza A, Calvo FA. Zapatero A, et al. Among authors: macias v. Lancet Oncol. 2015 Mar;16(3):320-7. doi: 10.1016/S1470-2045(15)70045-8. Epub 2015 Feb 19. Lancet Oncol. 2015. PMID: 25702876 Clinical Trial.
Comparative Effectiveness Research in Localized Prostate Cancer: A 10-Year Follow-up Cohort Study.
Garin O, Suárez JF, Guedea F, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Gutierrez C, Castells M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Garin O, et al. Among authors: macias v. Int J Radiat Oncol Biol Phys. 2021 Jul 1;110(3):718-726. doi: 10.1016/j.ijrobp.2020.12.032. Epub 2021 Jan 1. Int J Radiat Oncol Biol Phys. 2021. PMID: 33388360 Free article.
Mortality and biochemical recurrence after surgery, brachytherapy, or external radiotherapy for localized prostate cancer: a 10-year follow-up cohort study.
Suárez JF, Zamora V, Garin O, Gutiérrez C, Pont À, Pardo Y, Goñi A, Mariño A, Hervás A, Herruzo I, Cabrera P, Sancho G, Ponce de León J, Macías V, Guedea F, Vigués F, Castells M, Ferrer M; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Suárez JF, et al. Among authors: macias v. Sci Rep. 2022 Jul 22;12(1):12589. doi: 10.1038/s41598-022-16395-w. Sci Rep. 2022. PMID: 35869124 Free PMC article.
Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer.
Ferrer M, Suárez JF, Guedea F, Fernández P, Macías V, Mariño A, Hervas A, Herruzo I, Ortiz MJ, Villavicencio H, Craven-Bratle J, Garin O, Aguiló F; Multicentric Spanish Group of Clinically Localized Prostate Cancer. Ferrer M, et al. Among authors: macias v. Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):421-32. doi: 10.1016/j.ijrobp.2007.12.024. Epub 2008 Mar 5. Int J Radiat Oncol Biol Phys. 2008. PMID: 18325680
Quality-of-life impact of primary treatments for localized prostate cancer in patients without hormonal treatment.
Pardo Y, Guedea F, Aguiló F, Fernández P, Macías V, Mariño A, Hervás A, Herruzo I, Ortiz MJ, Ponce de León J, Craven-Bratle J, Suárez JF, Boladeras A, Pont À, Ayala A, Sancho G, Martínez E, Alonso J, Ferrer M. Pardo Y, et al. Among authors: macias v. J Clin Oncol. 2010 Nov 1;28(31):4687-96. doi: 10.1200/JCO.2009.25.3245. Epub 2010 Oct 4. J Clin Oncol. 2010. PMID: 20921463
134 results